Epithelioid trophoblastic tumor that requires fertility preservation: A case report and review of literature
Autor: | Yuanming Shen, Xiao-yun Wan, Xing Xie, Xue-qian Qian |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
Epithelioid trophoblastic tumor medicine.medical_treatment Fertility-preservation lcsh:Gynecology and obstetrics 03 medical and health sciences 0302 clinical medicine EP-EMA medicine Chemotherapy Fertility preservation Epithelioid Trophoblastic Tumor Etoposide lcsh:RG1-991 030219 obstetrics & reproductive medicine Hysterectomy medicine.diagnostic_test business.industry Obstetrics and Gynecology Chemotherapy regimen Surgery medicine.anatomical_structure Hysteroscopy Uterine cavity business medicine.drug |
Zdroj: | Taiwanese Journal of Obstetrics & Gynecology, Vol 59, Iss 5, Pp 736-739 (2020) |
ISSN: | 1028-4559 |
Popis: | Objective Epithelioid trophoblastic tumor (ETT) is very rare and few cases have been published in the English literature. Hysterectomy is the recommended treatment, due to the high rate of recurrence and mortality. The objective of this article is to present a rare case of ETT with fertility-preserving treatment and review published similar cases. Case report We report the case of ETT in a 19-year-old Chinese woman, who had a strong desire of fertility preservation. She presented with vaginal spotting and hysteroscopy showed an isolated solid mass (2.0 × 1.5 × 1.5 cm) at the right corner of the uterine cavity. Serum β-human chorionic gonadotropin (β-HCG) persisted at low level elevation about 100 IU/L. We treated her with a lesionectomy and 3 cycles EP-EMA (etoposide, cisplatin/etoposide, methotrexate and actinomycin) chemotherapy regimen. The patient is now in stable condition, without any signs of recurrence during 20 months of follow-up. Conclusion Fertility-preserving surgery would probably be a feasible and safe strategy for the patients whose lesions can be completely removed. |
Databáze: | OpenAIRE |
Externí odkaz: |